Levosimendan in High Risk Heart Valve Surgery

NCT00154115 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: levosimendan
DRUG: placebo

Sponsor

Kuopio University Hospital